IP Verse

Janssen Pharmaceutica Nv competitive analysis

Latest patents of Janssen Pharmaceutica Nv opposed by its competitors

Explore Janssen Pharmaceutica Nv's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 20, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3490560
Jan 22, 2025Methods Of Treating Prostate Cancer4
EP2234617
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters23
EP4005555
May 15, 2024Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations2
EP4025188
Jan 10, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP4025187
Jan 3, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP3744326
Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters10
EP3609497
Oct 12, 2022Combination Therapy For Prostate Cancer3
EP3311374
Jul 22, 2020Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques Therefor2
EP3280416
Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters10
EP3087098
Apr 8, 2020Anti-Vista Antibodies And Fragments2

Latest PTAB cases involving Janssen Pharmaceutica Nv

Discover the latest PTAB cases involving Janssen Pharmaceutica Nv, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 24, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Janssen Pharmaceutica Nv

IPR2020-00440Feb 7, 2020MYLAN LABORATORIESJANSSEN PHARMACEUTICAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Janssen Pharmaceutica Nv with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JANSSEN PHARMACEUTICA165 - 1
GENERICS UK226 - - -
HAMM & WITTKOPP74 - - -
TEVA PHARMACEUTICALS230181712